Showing results (871-880 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|June 1, 2023
Studying TIGIT activity against tumors through the generation of knockout miceAhmed Rishiq, Reem Bsoul, Ophir Pick, et al.
Oncoimmunology|June 1, 2023
Eribulin mesylate exerts antitumor effects via CD103Kazumasa Oya, Yoshiyuki Nakamura, Rei Watanabe, et al.
Oncoimmunology|October 9, 2023
Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptorJingjing Zhao, Jiebin Dong, Changwen Deng, et al.
Oncoimmunology|October 4, 2023
C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancerChen Zhang, Kankan Cao, Moran Yang, et al.
Oncoimmunology|October 25, 2023
Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissuesQikang Hu, Meredith L Frank, Yang Gao, et al.
Oncoimmunology|October 2, 2023
Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapySandra Martinez-Morilla, Myrto Moutafi, Aileen I Fernandez, et al.
Oncoimmunology|July 3, 2023
Short-term immune-checkpoint inhibition partially rescues perturbed bone marrow hematopoiesis in mismatch-repair deficient tumorsPaula Krone, Annabell Wolff, Julia Teichmann, et al.
Oncoimmunology|June 30, 2023
A Chemically Defined TLR3 Agonist with Anticancer ActivityJulie Le Naour, Sylvain Thierry, Sarah Adriana Scuderi, et al.
Oncoimmunology|March 12, 2026
Polarization of tumor-infiltrating macrophages predicts complete response to neoadjuvant treatment in patients with rectal cancerAylin Alkan, Fabian Byvald, Rode Grönkvist, et al.
Oncoimmunology|March 11, 2026
Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanomaJesse R Brown, Bernadette Pedersen, Georgina V Long, et al.
Pageof 379